Combination therapy using tnf and alfa-galactosyl ceramide

Details Combination therapy using tnf and alfa-galactosyl ceramide Combination therapy using tnf and alfa-galactosyl ceramide

A - Human Necessities

61

K

A61K 38/19 (2006.01) A61K 31/70 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2678088

The invention relates to the treatment of cancer. More specifically the invention shows that the anti-cancer activity in mammals can be augmented by administering to the mammalian host a combination of a synergistically effective amount of TNF and alfa-galactosylceramide.

L'invention se rapporte au traitement du cancer. En particulier, il est démontré selon l'invention que l'on peut augmenter l'activité anticancéreuse chez les mammifères en administrant au mammifère hôte une combinaison d'une quantité synergiquement efficace de TNF et d'un alfa-galactosylcéramide.

Affiliated with

Also associated with

Rating

Combination therapy using tnf and alfa-galactosyl ceramide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy using tnf and alfa-galactosyl ceramide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using tnf and alfa-galactosyl ceramide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1698798